DE69120731D1 - Verfahren zur Diagnose der senilen Demenz vom Alzheimer-Typ - Google Patents

Verfahren zur Diagnose der senilen Demenz vom Alzheimer-Typ

Info

Publication number
DE69120731D1
DE69120731D1 DE69120731T DE69120731T DE69120731D1 DE 69120731 D1 DE69120731 D1 DE 69120731D1 DE 69120731 T DE69120731 T DE 69120731T DE 69120731 T DE69120731 T DE 69120731T DE 69120731 D1 DE69120731 D1 DE 69120731D1
Authority
DE
Germany
Prior art keywords
diagnosis
procedure
senile dementia
alzheimer type
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69120731T
Other languages
English (en)
Inventor
Margaret E Appleyard
Brendan Mcdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE69120731D1 publication Critical patent/DE69120731D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69120731T 1990-06-01 1991-05-29 Verfahren zur Diagnose der senilen Demenz vom Alzheimer-Typ Expired - Lifetime DE69120731D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/531,613 US5595883A (en) 1990-06-01 1990-06-01 Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid

Publications (1)

Publication Number Publication Date
DE69120731D1 true DE69120731D1 (de) 1996-08-14

Family

ID=24118357

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120731T Expired - Lifetime DE69120731D1 (de) 1990-06-01 1991-05-29 Verfahren zur Diagnose der senilen Demenz vom Alzheimer-Typ

Country Status (4)

Country Link
US (1) US5595883A (de)
EP (1) EP0459454B1 (de)
CA (1) CA2042106A1 (de)
DE (1) DE69120731D1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
AU8259498A (en) * 1997-06-19 1999-01-04 Bioprobes, Inc. System and method for screening for dementia
AUPO943297A0 (en) * 1997-09-24 1997-10-16 University Of Melbourne, The Diagnostic test for alzheimer's disease
GB0012123D0 (en) * 2000-05-20 2000-07-12 Univ Dundee Alzheimer's disease assay
WO2002016951A2 (en) 2000-08-21 2002-02-28 The General Hospital Corporation Methods for diagnosing a neurodegenerative condition
EP2298361A3 (de) * 2001-04-27 2011-05-04 The General Hospital Corporation Okulare Diagnose der Alzheimer-Krankheit
US20090270717A1 (en) 2008-04-25 2009-10-29 Welch Allyn, Inc. Apparatus and method for diagnosis of optically identifiable ophthalmic conditions
US7575321B2 (en) 2003-10-30 2009-08-18 Welch Allyn, Inc. Apparatus and method of diagnosis of optically identifiable ophthalmic conditions
US8815508B2 (en) 2008-08-12 2014-08-26 Zinfandel Pharmaceuticals, Inc. Method of identifying disease risk factors
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
SG191399A1 (en) 2011-01-10 2013-08-30 Zinfandel Pharmaceuticals Inc Methods and drug products for treating alzheimer's disease
KR102406932B1 (ko) * 2019-06-10 2022-06-10 연세대학교 산학협력단 뇌신경계 질환의 진단용 바이오마커

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto

Also Published As

Publication number Publication date
US5595883A (en) 1997-01-21
EP0459454A1 (de) 1991-12-04
EP0459454B1 (de) 1996-07-10
CA2042106A1 (en) 1991-12-02

Similar Documents

Publication Publication Date Title
DE4192187T1 (de) Verfahren zur Abtrennung vom Ilmenit
DE69120731D1 (de) Verfahren zur Diagnose der senilen Demenz vom Alzheimer-Typ
DE69331092D1 (de) Verfahren zur Herstellung von intermetallischen Gussstücken
DE59107098D1 (de) Verfahren zur Herstellung von Photopolymerplatten
DE59008415D1 (de) Verfahren zur Herstellung pulverförmiger Aluminiumlegierungen.
DE59106899D1 (de) Verfahren zur Herstellung von Mercaptosilanen.
DE69117350D1 (de) Verfahren zur Herstellung magnetischer Aufzeichnungsträger
DE69319469D1 (de) Verfahren zur Herstellung eines Gitterrostes
DE69124657D1 (de) Verfahren zur Beurteilung der Qualität von Druckgusstücken
DE3888056D1 (de) Oxadiazolyl-azabicycloheptane zur Behandlung von seniler Demenz.
DE69115680D1 (de) Verfahren zur Anzeigedes Belastungszustands
GB9204585D0 (en) Method for diagnosing senile dementia of the alzheimer's type
DE69028357D1 (de) Verfahren zur Herstellung von Magnetköpfen
DE69102798D1 (de) Verfahren zur Herstellung von magnetischen Aufzeichnungsträgern.
DE69131264D1 (de) Verfahren zur Herstellung von Silazykloalkanen
DE69426381D1 (de) Verfahren zur Herstellung von Oxoverbindungen
DE69331256D1 (de) Verfahren zur Herstellung von Chlorogalliumphtalocyaninkristallen
ATE32601T1 (de) Verfahren zur optischen razematspaltung der alpha-naphthylpropionsaeuren.
DE69207019D1 (de) Verfahren zur Herstellung von Carbonylverbindungen
DE69103332D1 (de) Verfahren zur Herstellung von Methylisobutylketon.
DE69122169D1 (de) Verfahren zur Herstellung von Tonern
DE59207481D1 (de) Verfahren zur Herstellung von 2-Aminobenzthiazolen
DE59006663D1 (de) Verfahren zur Herstellung von magnetischen Aufzeichnungsträgern.
DE59010147D1 (de) Verfahren zur Herstellung von tertiären Carbonsäuren
DE69029938D1 (de) Ultraschallsonde und verfahren zur herstellung derselben

Legal Events

Date Code Title Description
8332 No legal effect for de